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ASBMT
and Marrow TransplantationGIRALT INSTALLED AS PRESIDENT;
BREDESON VICE PRESIDENT
Sergio A. Giralt, MD, has been
installed as President of the American
Society for Blood and Marrow Trans-
plantation. He is the Chief of the Adult
Bone Marrow Transplant Service at
Memorial Sloan-Kettering Cancer
Center.
Christopher N. Bredeson, MD, MSc,
who is professor of medicine in the Di-
vision of Hematology, University of
Ottawa and Head, Malignant Hematol-
ogy and BMT at the Ottawa Hospital, is
the newly elected and installed Vice
President, to become President in 2016.
Juliet N. Barker, MBBS, is the newly
elected and installed Secretary. She
is an Associate Member of Memorial
Sloan-Kettering Cancer Center (MSKCC),
Associate Professor of Medicine at Weill
Cornell Medical College, Associate
Attending at Memorial Hospital for
Cancer and Allied Diseases in New York,
and Director of the MSKCC Cord Blood
Transplant Program.
The installation of new ofﬁcers and
directors occurred at the Society’s
annual business meeting, the 2014 BMT
Tandem Meetings, on Feb. 28 in Grape-
vine/Dallas, Texas. The election was by
ballot among members of the Society in
December and January.
Newly elected and installed directors
are:
Margaret L. MacMillan, MD, MSc, of
the University of Minnesota Amplatz
Children’s Hospital in Minneapolis,
MN
Richard A. Nash, MD, of the Colorado
Blood and Cancer Institute in Denver,
CO
Pavan Reddy, MD, of the University
of Michigan Medical Center in Ann
Arbor, MI
All took ofﬁce at the close of the 2014
BMT Tandem Meetings.
Efﬁe W. Petersdorf, MD, was
elevated to President-Elect and will as-
sume the Presidency in 2015. She is a
Member of the Division of Clinical1083-8791/$ e see front matter  2014 American So
http://dx.doi.org/10.1016/j.bbmt.2014.02.017Research at the Fred Hutchinson Cancer
Research Center; a Professor of Medi-
cine at the University of Washington
School of Medicine, Seattle and an
Attending Physician of clinical bone
marrow transplant services at the Fred
Hutchinson Cancer Research Center and
Seattle Cancer Care Alliance, where she
is also HLA attending.THREE NEW INVESTIGATORS WIN
BBMT EDITORIAL AWARDS
Three medical scientists are the re-
cipients of editorial awards for new in-
vestigators for their articles published
in 2013 in Biology of Blood and Marrow
Transplantation. Selection of the win-
ning articles was by the BBMT Editorial
Board and the ASBMT Publications
Committee.
The Ernest McCulloch & James Till and
George Santos Awards are supported
jointly by grants from STEMCELL Tech-
nologies Inc., and STEMSOFT Software
Inc.
The ASBMT/BBMT Karl Blume Award
was established this year by ASBMT in
memory of Dr. Karl Blume.
Lucrezia Colonna, PhD (University
of Washington) is the recipient of the
Ernest McCulloch & James Till Award for
best basic science article by a new
investigator. Her article was “IL-17 gene
ablation does not impact Treg-mediated
suppression of GVHD following bone
marrow transplantation.”
Willemijn Hobo, PhD (Radboud
University) is the recipient of the George
Santos Award for best clinical science
article by a new investigator. Her article
was “Association of disparities in known
minor histocompatibility antigens with
relapse-free survival and GVHD after
allogeneic SCT.”
Sara Nikiforow, MD, PhD (Dana-
Farber Cancer Institute) is recipient
of the ASBMT/BBMT Karl Blume Award
for clinical science article by a new
investigator. Her article was “A phase I
study of alemtuzumab for therapy of
steroid-refractory chronic graft-versus-
host disease.”ciety for Blood and Marrow Transplantation.The awards were presented by ASBMT’s
President, C. Fred LeMaistre, MD, during
the 2014 BMT Tandem Meetings in
Grapevine/Dallas, Texas.SIX ABSTRACTS WERE CHOSEN AS
BEST FOR THE 2014 BMT TANDEM
MEETINGS
A total 528 abstracts from 30 coun-
tries were accepted for the 2014 BMT
Tandem Meetings.
Six of the abstracts were selected for
awards by the Abstract Review
Committees.
Recipients of the ASBMT Best Ab-
stract Awards for Basic Science Research
were:
Robert Jenq, MD e “Identiﬁcation of
Intestinal Commensal Bacteria Protec-
tive Against GVHD in Mice and
Humans.”
Dominik Schneidawind, MD e
“CD4þ Invariant Natural Killer T
Cells Protect from Acute Graft-Versus-
Host Disease Lethality through a Dra-
matic Expansion of Donor-Derived
CD4þFoxP3þ Regulatory T Cells”
Yusuke Shono, MD, PhD e
“ATG16L1 Prevents Lethal T-Cell Allor-
eactivity Mediated By Dendritic Cells.”
Recipients of the CIBMTR Best Ab-
stract Awards for Clinical Research
were:
Sung-Yun Pai, MD e “Retrospective
Study of 240 Patients with Severe
Combined Immunodeﬁciency Trans-
planted from 2000-2009: A Report from
the Primary Immune Deﬁciency Treat-
ment Consortium of North America”
Joseph Pidala, MD, MS e “HLA-
Mismatch Is Associated with Worse
Outcomes after Myeloablative Condi-
tioning and Unrelated Donor Hemato-
poietic Cell Transplantation: A CIBMTR
Analysis.”
Carlos Ramos, MD e “Clinical Re-
sponses in Patients Infused with T
Lymphocytes Redirected to Target
Kappa-Light Immunoglobulin Chain.”
The clinical research awards are
supported by a grant from WellPoint,
Inc.
